In a letter to the Biden Administration, the organization conveyed recommendations to help ensure that eligible individuals can efficiently and effectively access additional COVID-19 doses at their local pharmacies.
Jardiance is now FDA approved to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure with reduced ejection fraction.
Teva won a U.S. appeals court ruling that upheld three patents on its Ajovy migraine drug, though six other patents on the treatment were ruled invalid, according to a report.
Pharmacy Fulfillment by iA, SmartPod and iA Therapy Management Solutions, enabled by NEXiA, are three new tools from iA intended to enhance the pharmacist-patient relationship.